Brian Elsbernd - Feb 14, 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CPRX	Restricted Stock Units	Award	$0	+29K	+3.15%	$0.00	951K	Feb 14, 2022	Common Stock	29K		Direct	F1, F2, F3

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2	Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025.
F3	Shares of common stock will be delivered to the Reporting Person within sixty (60) days of vesting.